- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Milestone Pharmaceuticals Inc (MIST)
Milestone Pharmaceuticals Inc stock price live, this page displays NASDAQ MIST stock exchange data. View the MIST premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Milestone Pharmaceuticals Inc real time stock price chart below.
What Is the Milestone Pharmaceuticals Inc Stock Price Today?
The Milestone Pharmaceuticals Inc stock price today is 0.5200.
What Is the Stock Symbol for Milestone Pharmaceuticals Inc?
The stock symbol for Milestone Pharmaceuticals Inc is "MIST."
What Stock Exchange Does Milestone Pharmaceuticals Inc Trade On?
Milestone Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Milestone Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Milestone Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MIST quote. (ISIN: CA59935V1076)
What Is the Milestone Pharmaceuticals Inc Stock Price Today?
The Milestone Pharmaceuticals Inc stock price today is 0.5200.
What Is the Stock Symbol for Milestone Pharmaceuticals Inc?
The stock symbol for Milestone Pharmaceuticals Inc is "MIST."
What Stock Exchange Does Milestone Pharmaceuticals Inc Trade On?
Milestone Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Milestone Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Milestone Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MIST quote. (ISIN: CA59935V1076)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5000
0.7000
52 wk Range
0.5000
3.0600
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.50000.7000
52 wk Range
0.50003.0600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MIST Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
5.5714
Upside
+971.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.5714
(+971.43% Upside)
Milestone Pharmaceuticals Inc Earnings Call Summary for Q3/2026
- Milestone beat Q3 estimates with $2.96M revenue vs $1.2M forecast; loss of $0.18/share vs $0.22 expected; shares rose 6.06% premarket.
- CARDAMYST prescriptions jumped 50% to ~1,800 in Q3 from Q2; commercial coverage expanded to two-thirds of insured lives.
- Company announced 30% operating expense reduction by Q1 2027, extending cash runway into late 2028 to cover phase III AFib-RVR trial readout.
- Net loss widened to $25.8M from $11.9M year-over-year as SG&A surged 206% to support commercial rollout; nine-month loss reached $80.5M.
- Management expects Q4 prescription growth, potential Q1 2027 seasonal softness, then renewed growth; AFib-RVR phase III results expected H2 2028.
Last Updated: 2026-11-13, 09:32 a/m
Read Full TranscriptEarnings
Latest Release
Nov 13, 2026
EPS / Forecast
-0.18 / -0.22
Revenue / Forecast
2.96M / 1.2M
Compare MIST to Peers and Sector
Metrics to compare | MIST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMISTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −0.1x | −0.2x | |
PEG Ratio | −0.06 | 0.00 | 0.00 | |
Price/Book | 4.0x | 1.4x | 2.6x | |
Price / LTM Sales | 31.3x | 2.1x | 2.8x | |
Upside (Analyst Target) | - | 87.6% | 65.0% | |
Fair Value Upside | Unlock | 10.6% | 9.6% | Unlock |
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Milestone Pharmaceuticals (MIST) Stock Price Today?
The Milestone Pharmaceuticals stock price today is 0.5200 USD.
What Stock Exchange Does Milestone Pharmaceuticals Trade On?
Milestone Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Milestone Pharmaceuticals?
The stock symbol for Milestone Pharmaceuticals is "MIST."
What Is the Milestone Pharmaceuticals Market Cap?
As of today, Milestone Pharmaceuticals market cap is 92.3200M USD.
What Is Milestone Pharmaceuticals's Earnings Per Share (TTM)?
The Milestone Pharmaceuticals EPS (TTM) is -0.71.
When Is the Next Milestone Pharmaceuticals Earnings Date?
Milestone Pharmaceuticals will release its next earnings report on Mar 25, 2027.
From a Technical Analysis Perspective, Is MIST a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Milestone Pharmaceuticals Stock Split?
Milestone Pharmaceuticals has split 0 times.
How Many Employees Does Milestone Pharmaceuticals Have?
Milestone Pharmaceuticals has 38 employees.
What is the current trading status of Milestone Pharmaceuticals (MIST)?
As of Nov 14, 2026, Milestone Pharmaceuticals (MIST) is trading at a price of 0.5200 USD, with a previous close of 0.6552 USD. The stock has fluctuated within a day range of 0.5000 USD to 0.7000 USD, while its 52-week range spans from 0.5000 USD to 3.0600 USD.
What Is Milestone Pharmaceuticals (MIST) Price Target According to Analysts?
The average 12-month price target for Milestone Pharmaceuticals is 5.5714 USD, with a high estimate of 8 USD and a low estimate of 1 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +971.43% Upside potential.
What Is the MIST Premarket Price?
MIST's last pre-market stock price is 0.6949 USD. The pre-market share volume is 226,620.0000, and the stock has decreased by 0.0397, or 6.0600%.
What Is the MIST After Hours Price?
MIST's last after hours stock price is 0.5099 USD, the stock has decreased by -0.0101, or -1.9400%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.